Ajanta Pharma (AJANTPHARM) — Financial Results

📢 Key Event
Q1 FY2027 unaudited financial results announcement and earnings conference call

💡 Investor Takeaway
Shareholders can listen to management discuss Q1 FY2027 results and ask questions during the scheduled call.

Ajanta Pharma announced its Q1 FY2027 unaudited financial results will be released on 30 July 2026 at 16:30 IST, followed by an earnings conference call to discuss performance and answer questions. The call will be accessible globally via dial-in numbers and webcast on the company website, with playback available 120 minutes post-call.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AJANTPHARM ✨ Ask AI About This

About Ajanta Pharma Limited (AJANTPHARM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹39,694.55 Cr P/E: 37.6 ROE: 23.3% ROCE: 29.4%

View full AJANTPHARM stock details →

📡 Get AI alerts when AJANTPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AJANTPHARM — Free

💡 Ask AI about this filing

"When will Q1 FY2027 results be released?" "Where to access the earnings call?" "What topics will management discuss?"

Ask AI Free →

📊 More AJANTPHARM filings

See all AJANTPHARM filings →

🔥 Also filed on 20 July 2026

ANDHRAPAP ANDHRA PAPER LIMITED Annual Report CANHLIFE Canara HSBC Life Insurance Company Limited Financial Results CANBK Canara Bank Corporate Action KROSS Kross Limited Financial Results IDFCFIRSTB IDFC First Bank Limited Financial Results J&KBANK The Jammu & Kashmir Bank Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AJANTPHARM files new disclosures

Track AJANTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.